Skip to main content
. 2021 Jul 22;26:101320. doi: 10.1016/j.inat.2021.101320

Table 1.

Summary of the previous case reports.

Study Country Design Intervention Population Results and Outcomes
Zhou 2020 et al. [8] USA Case report One gram intravenous methylprednisolone Man with optic neuritis and myelitis post-COVID-19 Infection. Improvement in visual acuity and complete resolution of retinal findings and optic disc edema
Sawalha 2020 et al. [9] USA Case report One gram of methylprednisolone every 24 h for five days Man with bilateral optic neuritis post-COVID-19 infection. Complete restoration of vision in the left eye, while the right eye did not show complete recovery.
Finsterer 2021 et al. [11] Brazil Case series Intravenous methylprednisolone and oral prednisone Cases with optic neuritis and mimic retinitis post-COVID-19 infection. Improvement in vision, some patients' had complete resolution while some did not sow complete recovery yet
François 2021 et al. [12] France Case report Oral and topical corticosteroids Woman with ocular neuropathy and pan-uveitis post-COVID. Permanent visual acuity loss without recovery
Benito-Pascual 2020 et al. [10] Spain Case report 60 mg oral prednisone, 400 mg hydroxychloroquine and 400 mg lopinavir for six days Woman with pan-uveitis and optic neuritis post-COVID-19 infection. Improvement of visual acuity, but without complete recovery